SCHEMBL29655103

SCHEMBL29655103

Nc1cc(-c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)cnc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 12/20 0.53
ENPP1 P22413 1/20 0.52
LMNA P02545 1/20 0.50
HDAC1 Q13547 2/20 0.49
AR P10275 4/20 0.48
PARP2 Q9UGN5 3/20 0.48
PIK3CA P42336 1/20 0.48
TUBB4A P04350 1/20 0.48
TUBB P07437 1/20 0.48
TUBA3C P0DPH7 1/20 0.48
TPI1 P60174 1/20 0.48
TUBA1B P68363 1/20 0.48
TUBA4A P68366 1/20 0.48
TUBB4B P68371 1/20 0.48
TUBB3 Q13509 1/20 0.48
TUBB2A Q13885 1/20 0.48
TUBB8 Q3ZCM7 1/20 0.48
TUBA3E Q6PEY2 1/20 0.48
TUBA1A Q71U36 1/20 0.48
TUBA1C Q9BQE3 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19748904 1.00 PARP1 (0.53) PARP1ENPP1LMNAHDAC1AR
SCHEMBL29655280 0.87 AR (0.49) PARP1ENPP1LMNAHDAC1AR
SCHEMBL19747595 0.87 AR (0.49) PARP1ENPP1LMNAHDAC1AR
SCHEMBL19748615 0.86 PARP1 (0.54) PARP1ENPP1LMNAHDAC1AR
SCHEMBL29655020 0.86 PARP1 (0.54) PARP1ENPP1LMNAHDAC1AR
SCHEMBL30089698 0.85 ENPP1 (0.53) PARP1ENPP1LMNAHDAC1AR
SCHEMBL19748667 0.85 ENPP1 (0.53) PARP1ENPP1LMNAHDAC1AR
SCHEMBL4572859 0.84 ENPP1 (0.56) PARP1ENPP1LMNAARPARP2
SCHEMBL29655172 0.83 LMNA (0.55) PARP1ENPP1LMNAHDAC1AR
SCHEMBL21528284 0.83 LMNA (0.55) PARP1ENPP1LMNAHDAC1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-B Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer 加利福尼亚大学董事会 2022-05-27 CN disclosed